Table 2.
Sensitivity analysis of pooled prevalence of FGM for each study being removed one at a time.
| Study Omitted | FGM Pooled prevalence (95% CI) |
|---|---|
| Olijira T et al./2016 | 77.16(54.87,99.45) |
| Tamire M et al./2013 | 77.01(54.74,99.29) |
| Bogale D et al./2014 | 77.22(54.99,99.45) |
| Shay TZ et al./2010 | 80.13(57.96,102.30) |
| Yirga WS et al./2012 | 76.45(54.14,98.76) |
| Abdisa B et al./2017 | 76.74(54.58,98.90) |
| Gebremariam K et al./2016 | 76.99(54.74,99.23) |
| Shiferaw D et al./2017 | 77.26(54.99,99.52) |
| Degefa H et al./2017 | 76.46(54.27,98.64) |
| Andualem M/2013 | 77.26(55.00,99.52) |
| Andualem M/2016 | 76.24(53.99,98.50) |
| Chuluko BG et al./2018 | 76.53(54.24,98.82) |
| Belda SS et al./2017 | 78.04(55.78,100.30) |
| Gudu W et al./2017 | 76.48(54.35,98.62) |
| Hussein MA et al./2013 | 76.58(54.42,98.74) |
| Gajaa M et al./2016 | 76.12(54.15,98.09) |
| Gebrekirstos K et al./2014 | 81.58(74.43,88.74) |
| Argaw A et al./2002 | 76.22(54.10,98.34) |
| EDHS/2016 | 77.97(53.87,66.06) |